NEW YORK (GenomeWeb News) — Galapagos today said it plans to acquire Inpharmatica, a UK-based drug discovery database company in a stock deal that potentially worth €19.1 million ($25.4 million).
 
Galapagos said it estimates that Inpharmatica’s ongoing business is worth €6.5 million, the company has €6 million for the cash, and has a potential to earn around €6.6 million in milestones.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.